Back to Search
JAMES BEARDEN, MD
MD
Hematology & Oncology Physician
NPI: 1447256730Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
5674(SC)
Research & Publications (20)
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
PMID 19066370·JAMA·2009
3-trial
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
PMID 19129205·Ann Oncol·2009
3-trial
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
PMID 18375894·J Clin Oncol·2008
3-trial
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
PMID 18189296·Cancer·2008
3-trial
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
PMID 17470735·J Natl Cancer Inst·2007
3-trial
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
PMID 17394940·Int J Radiat Oncol Biol Phys·2007
3-trial
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network.
PMID 17823908·Cancer·2007
3-trial
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
PMID 17545848·J Thorac Oncol·2007
3-trial
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.
PMID 17513815·J Clin Oncol·2007
3-trial
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
PMID 17470850·J Clin Oncol·2007
3-trial
Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer.
PMID 17409967·J Thorac Oncol·2006
3-trial
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
PMID 17409984·J Thorac Oncol·2006
3-trial
Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience.
PMID 17022922·J Soc Integr Oncol·2006
6-review
The interplay of memory and judgment processes in effects of aging on hindsight bias.
PMID 16938042·J Exp Psychol Learn Mem Cogn·2006
4-observational
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
PMID 16505409·J Clin Oncol·2006
3-trial
Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer.
PMID 16062075·Am J Clin Oncol·2005
3-trial
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
PMID 15856431·Cancer·2005
3-trial
A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
PMID 15310415·Clin Lung Cancer·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 E WOOD ST
SPARTANBURG, SC 29303 - Phone
- (864) 560-7050
Quick Facts
- NPI
- 1447256730
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile